Health Care & Life Sciences » Pharmaceuticals | Changchun High & New Technology Industries

Changchun High & New Technology Industries | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
421
444
538
677
928
1,463
Depreciation, Depletion & Amortization
68
75
79
84
84
103
Other Funds
5
50
73
1,580
200
25
Funds from Operations
455
513
609
796
1,174
1,600
Changes in Working Capital
43
233
162
470
722
658
Net Operating Cash Flow
499
280
771
326
453
942
Capital Expenditures
228
102
228
185
231
Sale of Fixed Assets & Businesses
-
-
19
4
36
Purchase/Sale of Investments
-
27
67
1,495
346
Net Investing Cash Flow
232
110
295
1,665
153
Cash Dividends Paid - Total
26
53
66
105
136
Issuance/Reduction of Debt, Net
68
15
1
18
5
Net Financing Cash Flow
99
118
139
1,457
331
Net Change in Cash
167
52
338
119
273
Free Cash Flow
270
178
543
141
221
Deferred Taxes & Investment Tax Credit
15
14
12
4
27
9
Other Sources
-
-
-
12
3
Exchange Rate Effect
-
-
2
1
1
Other Uses
4
-
-
-
1

About Changchun High & New Technology Industries

View Profile
Address
5/F, Huoju Building
Changchun Jilin 130021
China
Employees -
Website http://www.cchn.com.cn
Updated 07/08/2019
Changchun High & New Technology Industries (Group), Inc. engages in the research and development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. It involves in real estate development and leasing, and property management. The company was founded in June 1993 and is headquartered in Changchun, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.